Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

The discount affects several of its older long- and short-acting insulin brands in both vial and pre-filled pen formats, including Levemir and Novolin, which will fall 65%, and the NovoLog and ...

Short-acting insulin covers the spike in glucose that comes with meals. Long-acting insulin lasting around 24 hours manages the time between meals and at night. Covering three meals and the rest ...

Until the advent of lente insulin the preparation of insulins ... In the preparation of these long-acting insulins a phosphate buffer has commonly been used. Under these conditions, the use ...

Wright and other advocates for diabetes patients who need insulin to survive worry the nation's supply has become unreliable.

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported ... patients with Type 1 diabetes need steady access to short-acting ...